MedPath

ChemRar Research and Development Institute, LLC

Ownership
Private
Employees
-
Market Cap
-
Website

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Phase 3
Conditions
Anxiety Disorder Generalized
Interventions
Drug: Placebo
Drug: Afobazol
First Posted Date
2020-10-22
Last Posted Date
2020-10-22
Lead Sponsor
ChemRar Research and Development Institute, LLC
Target Recruit Count
200
Registration Number
NCT04598867

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Phase 2
Completed
Conditions
Anxiety Disorder Generalized
Interventions
Drug: Placebo
First Posted Date
2020-08-24
Last Posted Date
2020-08-24
Lead Sponsor
ChemRar Research and Development Institute, LLC
Target Recruit Count
129
Registration Number
NCT04524975
Locations
🇷🇺

St. Petersburg "Psychoneurological dispensary #5", Saint Petersburg, Russian Federation

🇷🇺

"Research Center for Mental Health" Scientific Institution, Moscow, Russian Federation

🇷🇺

Clinical Center LLC "Doctor SAN", Saint Petersburg, Russian Federation

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath